Ibalizumab
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Progress toward longer-acting antiretroviral regimens for adult HIV treatment.
Journal: Expert review of clinical pharmacology
Published: August 26, 2026
A precautionary tale of lenacapavir drug-drug interactions: A case series of two persons living with HIV receiving long-acting injections.
Journal: International journal of STD & AIDS
Published: June 18, 2026
People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and Outcomes.
Journal: AIDS patient care and STDs
Published: June 05, 2026
A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.
Journal: Open forum infectious diseases
Published: March 27, 2026
HIV-1 Non Group-M Phenotypic Susceptibility to Ibalizumab.
Journal: Journal of medical virology
Published: September 02, 2025
Combined Use of Ibalizumab and Lenacapavir for the Treatment of Multidrug-resistant HIV-1: A Case Series.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 23, 2025
Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection.
Journal: International journal of molecular sciences
Published: June 12, 2025
Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 04, 2025
Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 29, 2025
PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives".
Journal: The new microbiologica
Published: November 19, 2024
Investigating the combination of Temsavir and entry inhibitors on HIV replication: Synergistic and antagonistic effects observed against various R5-tropic envelopes.
Journal: Virology
Published: October 30, 2024
Last Updated: 09/26/2026